Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
S.BuffaJ
No artifact, hepatitis E is emerging
Hepatic effects and mechanisms of injury The liver, being the primary site for xenobiotic metabolism and lipid/glucose regulation, is highly susceptible to the systemic effects of vaping aerosols
Andrea Corona MapLight reports mixed results in Schizophrenia trial In their Phase 2 ZEPHR trial, MapLights novel oral drug for schizophrenia, the Ml/M4 muscarinic agonist ML-007C-MA, successfully hit its primary endpoint but only for the twice-daily version, not the once-daily dose
Ceruloplasmin dysfunction and therapeutic potential for parkinson disease
US$ 21.39
US$ 24.47
US$ 23.32
US$ 28.69
